株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

糖尿病治療装置の世界市場:機会分析および産業予測

Diabetes Care Devices & Drugs Market - Global Opportunity Analysis And Industry Forecast (2017-2022)

発行 Meticulous Market Research Pvt. Ltd. 商品コード 569162
出版日 ページ情報 英文
即納可能
価格
本日の銀行送金レート: 1USD=108.48円で換算しております。
Back to Top
糖尿病治療装置の世界市場:機会分析および産業予測 Diabetes Care Devices & Drugs Market - Global Opportunity Analysis And Industry Forecast (2017-2022)
出版日: 2017年10月23日 ページ情報: 英文
概要

当レポートでは、世界の糖尿病治療装置市場を調査分析し、市場概要、セグメント別の市場分析、地域別分析、競合情勢、企業プロファイルなど、体系的な情報を提供しています。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場考察

  • イントロダクション
  • 促進要因
  • 抑制要因
  • 機会
  • 課題
  • 規制分析
  • 市場シェア分析

第5章 糖尿病治療装置市場:種類別

  • イントロダクション
  • 糖尿病モニタリング装置
    • 持続式血糖モニタリング (CGM) 装置
    • テストストリップ
    • ランセット
    • 血糖自己測定 (SMBG) 装置
    • ヘモグロビンA1cテストキット
  • インスリンデリバリー装置
    • インスリンシリンジ
    • インスリンペン
    • インスリンポンプ
    • インスリンジェットインジェクター

第6章 糖尿病治療装置市場:種類別

  • イントロダクション
  • インスリン
    • 即効型インスリン
    • 短時間作用型インスリン
    • 中間型インスリン
    • 持続型 (長時間作用型) インスリン
  • 経口血糖降下薬
  • 非インスリン注射薬

第7章 糖尿病治療装置市場:地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋
  • その他 (RoW)

第8章 競合情勢

  • 協力、提携 & 合意
  • 認可
  • 新製品発売
  • 拡大
  • 買収
  • その他

第9章 企業プロファイル

  • Novo Nordisk A/S
  • Ypsomed AG
  • Abbott Laboratories
  • Ascensia Diabetes Care Holdings AG
  • Eli Lilly And Company
  • Hoffmann-La Roche Ltd.
  • Johnson & Johnson
  • Medtronic Plc
  • Becton, Dickinson And Company
  • テルモ
  • Sanofi S.A.
  • Merck & Co., Inc.
  • Novartis Ag
  • Astrazeneca
  • Boehringer Ingelheim GmbH

第10章 付録

図表リスト

目次

Title:
Global Diabetes Care Devices & Drugs Market
by Type of Devices (Continuous Blood Glucose Monitoring Devices, Test Strips, Lancets, Self-monitoring Devices, Haemoglobin A1c Testing Kits, Insulin Syringes, Insulin Pens, Insulin Pumps, Insulin Jet Injectors), and Drugs (Insulin, Oral Hypoglycaemic Agents, and Non-Insulin Injectable) - Global Opportunity Analysis and Industry Forecast To 2022 .

Diabetes is one of the largest global health emergencies of the 21st century. Each year more and more people live with this condition, which can result in life-changing complications. In addition to the 415 million adults who are estimated to have diabetes globally in 2015, there are 318 million adults with impaired glucose tolerance, which puts them at high risk of developing the chronic disease in the future. The incidence & prevalence of diabetes is growing with rising obesity rates, changing lifestyle and dietary habits, and growing ageing population. Therefore, given the huge numbers of diabetics worldwide and the huge financial implications associated with diabetes and related further health complications, there is a substantial market potential in the global diabetes care devices & drugs market in the next 5-10 years. The global diabetes care devices & drugs market are expected to grow at a CAGR of 5.2% from 2017 to 2022 to reach $85,591.2 million by 2022.

Following a comprehensive research on the global diabetes care devices & drugs market and an in-depth analysis of the market scenario, the report carries out an impact analysis of the key industry drivers, restraints, and opportunities, listed in the market insights segment. Increasing incidence & prevalence of diabetes, technological advancements, rise in obesity, and increasing sedentary lifestyle and improper diet are the key market drivers covered in the report which will support the industry growth in the forecast period. However, high cost associated with diagnosis and treatment, reimbursement issues, and lack of awareness are the major pain points, restraining the adoption of the diabetes care devices & drugs market in various countries across the globe.

The report further gives an extensive outlook on the multifarious segments and sub-segments in both diabetes care devices and drugs market. The diabetes care devices market further talks about the trends impacting the growth of diabetes monitoring devices and insulin delivery devices including their sub-segments. The diabetes care drugs market in detail speaks about insulin, oral-hypoglycemic drugs, and non-insulin injectable drugs.

An exhaustive analysis of the geographical scenario of the industry for the five major geographies: North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa is included in the geographical analysis section. These regions are further analyzed at a country level with the detailed qualitative and quantitative analysis. The geographical analysis provides detailed insights on the key trends of the industry in the listed regions & countries, identifying the disease incidence & prevalence, demographic & economic impact, government & private investments, and regulatory scenario. The report identifies North America to be the largest market, followed by Europe, Asia-Pacific, Latin America and Middle East & Africa. The geographical analysis section also comments on the key market players shaping the growth of the industry in the respective countries.

Global Diabetes Care Devices & Drugs Market, by Geography, 2017-2022

The report also includes the competitive landscape based on extensive assessment of the key strategic developments adopted by leading market participants in the industry over the past 3 years (2015-2017). The study has also incorporated the market share analysis of leading players in each of the diabetes care devices and drugs market, and detailed profiles of 15 top market players across the value chain of the industry, including detailed financial performance, product offerings, and strategic growth initiatives of each player.

The key players operating in the global diabetes care devices & drugs market are Novo Nordisk A/S (Denmark), Ypsomed AG (Switzerland), Abbott Laboratories (U.S.), Ascensia Diabetes Care Holdings AG (Switzerland), Eli Lilly and Company (U.S.), Hoffmann-La Roche Ltd.(Switzerland), Johnson & Johnson (U.S.), Medtronic PLC (Ireland), Becton, Dickinson and Company (U.S.), Terumo Corporation (Japan), Sanofi S.A. (France), Merck & Co., Inc.(U.S.), Novartis AG (Switzerland), AstraZeneca PLC (U.K.), and Boehringer Ingelheim GmbH (Germany).

Key questions answered in the report:

Increasing incidence & prevalence of diabetes to drive the adoption of diabetes care devices & drugs market

  • How does the penetration of diabetes care devices differ from the penetration of diabetes care drugs?
  • Which are the high growth market segments in terms of product type, and regions/countries?

The North American diabetes care devices & drugs market favors both larger and local manufacturers that compete in multiple segments

  • Who are the top competitors in this market and what strategies do they employ to gain shares?
  • What is driving the growth and which market segments have the most potential for revenue expansion over the forecast period?
  • What strategies should new companies looking to enter this market use to compete effectively?
  • What are the major drivers, restrains, and opportunities in the global diabetes care devices & drugs market?
  • Who are the major players in various countries and what share of the market do they hold?
  • What are the geographical trends and high growth regions/ countries?

Recent collaborations, partnerships, expansions, and agreements taken place in the diabetes care devices & drugs space.

  • What companies have recently formed partnerships/collaborations/agreements and how will these unions affect the competitive landscape of the diabetes care devices & drugs space?
  • Which companies have recently received approvals for innovative devices/drugs and how will these approvals promote a competitive advantage?
  • Who are the major players in the global diabetes care devices & drugs market and what share of the market do they hold?
  • Who are the local emerging players in the global diabetes care devices & drugs market and how do they compete with the global players?

Scope of the Report

Market by Product

Diabetes care devices

  • Diabetes monitoring devices
    • Test strips
    • Self-monitoring devices
    • Continuous blood glucose monitoring devices
    • Lancets
    • Hemoglobin A1c testing kits
  • Insulin delivery devices
    • Insulin Pens
    • Insulin Syringes
    • Insulin Pumps
    • Insulin Jet Injectors

Diabetes care drugs

  • Insulin
    • Rapid-acting insulin drugs
    • Short-acting insulin drugs
    • Intermediate-acting insulin drugs
    • Long-acting insulin drugs
  • Oral-hypoglycaemic drugs
    • Biguanides (Metformin)
    • Sulfonylureas
    • Meglitinides/ Phenylalanine analogues
    • Thiazolidinedione analogues
    • α-glucosidase inhibitors
    • DPP-IV Inhibitors
  • Non-insulin injectable drugs

Market by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Rest of Asia-Pacific
  • Rest of World
    • Latin America
    • The Middle East and Africa

Table of Contents

1. Introduction

  • 1.1. Market Ecosystem
  • 1.2. Currency and Limitations
    • 1.2.1. Currency
    • 1.2.2. Limitations
  • 1.3. Key Stakeholders

2. Research Methodology

  • 2.1. Research Process
    • 2.1.1. Secondary Research
    • 2.1.2. Primary Research
    • 2.1.3. Market Size Estimation

3. Executive Summary

4. Market Insights

  • 4.1. Introduction
  • 4.2. Drivers
    • 4.2.1. Increasing Incidence & Prevalence of Diabetes
    • 4.2.2. Technological Advancements
    • 4.2.3. Rise in Obesity
    • 4.2.4. Increasing Sedentary Lifestyle and Improper Diet
    • 4.2.5. Other Drivers
  • 4.3. Restraints
    • 4.3.1. High Cost Associated with Diagnosis and Treatment
    • 4.3.2. Reimbursement Issues
    • 4.3.3. Lack of Awareness
    • 4.3.4. Other Restraints
  • 4.4. Opportunities
    • 4.4.1. Development of New Formulations and Insulin Delivery Technologies
    • 4.4.2. Other Opportunities
  • 4.5. Challenges
    • 4.5.1. Stringent Regulations and Registration Process
    • 4.5.2. Other Challenges
  • 4.6. Regulatory Analysis
    • 4.6.1. North America
    • 4.6.2. Europe
    • 4.6.3. Asia-Pacific
  • 4.7. Market Share Analysis
    • 4.7.1. Diabetes Care Devices
    • 4.7.2. Diabetes Care Drugs

5. Diabetes Care Devices Market, By Type

  • 5.1. Introduction
  • 5.2. Diabetes Monitoring Devices
    • 5.2.1. Continuous Blood Glucose Monitoring Devices
    • 5.2.2. Test Strips
    • 5.2.3. Lancets
    • 5.2.4. Self-Monitoring Blood Glucose Devices
    • 5.2.5. Haemoglobin A1c Testing Kits
  • 5.3. Insulin Delivery Devices
    • 5.3.1. Insulin Syringes
    • 5.3.2. Insulin Pens
    • 5.3.3. Insulin Pumps
    • 5.3.4. Insulin Jet Injectors

6. Diabetes Care Drugs Market, By Type

  • 6.1. Introduction
  • 6.2. Insulin
    • 6.2.1. Rapid Acting Insulin
    • 6.2.2. Short Acting Insulin
    • 6.2.3. Intermediate Acting Insulin
    • 6.2.4. Long Acting Insulin
  • 6.3. Oral Hypoglycaemic Drugs
    • 6.3.1. Sulfonylureas
    • 6.3.2. Biguanides
    • 6.3.3. Meglitinides / Phenylalanines Analogues
    • 6.3.4. Thiazolidinediones
    • 6.3.5. Alpha-Glucosidase Inhibitors
    • 6.3.6. Di-Peptidyl Peptidase -4(DPP-4) Inhibitor
  • 6.4. Non-Insulin Injectable Drugs

7. Diabetes Care Devices & Drugs Market, By Geography

  • 7.1. Introduction
  • 7.2. North America
    • 7.2.1. U.S.
    • 7.2.2. Canada
  • 7.3. Europe
    • 7.3.1. Germany
    • 7.3.2. France
    • 7.3.3. Italy
    • 7.3.4. Spain
    • 7.3.5. U.K.
    • 7.3.6. RoE
  • 7.4. Asia-Pacific
    • 7.4.1. Japan
    • 7.4.2. China
    • 7.4.3. India
    • 7.4.4. RoAPAC
  • 7.5. RoW
    • 7.5.1. Latin America
    • 7.5.2. Middle East & Africa

8. Competitive Landscape

  • 8.1. Collaborations, Partnerships & Agreements
  • 8.2. Approvals
  • 8.3. New Product Launches
  • 8.4. Expansions
  • 8.5. Acquisitions
  • 8.6. Others

9. Company Profiles (Business overview, ,Financials, Product portfolio, and Recent developments)

  • 9.1. Novo Nordisk A/S
  • 9.2. Ypsomed AG
  • 9.3. Abbott Laboratories
  • 9.4. Ascensia Diabetes Care Holdings AG
  • 9.5. Eli Lilly And Company
  • 9.6. Hoffmann-La Roche Ltd.
  • 9.7. Johnson & Johnson
  • 9.8. Medtronic Plc
  • 9.9. Becton, Dickinson And Company
  • 9.10. Terumo Corporation
  • 9.11. Sanofi S.A.
  • 9.12. Merck & Co., Inc.
  • 9.13. Novartis Ag
  • 9.14. Astrazeneca
  • 9.15. Boehringer Ingelheim GmbH

10. Appendix

  • 10.1. Questionnaire
  • 10.2. Available Customization

List of Tables

  • Table 1: Diabetes Care Devices & Drugs Market Drivers: Impact Analysis (2017-2022)
  • Table 2: Technological Advancements, By Company
  • Table 3: Diabetes Care Devices & Drugs Market Restraints: Impact Analysis (2017-2022)
  • Table 4: Proportion And Number of People (20-79 Years) Living With Diabetes Who Are Undiagnosed, 2015
  • Table 5: Global Diabetes Care Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 6: Global Diabetes Care Devices Market Size, by Country/ Region, 2015-2022 (USD Million)
  • Table 7: Global Diabetes Monitoring Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 8: Global Diabetes Monitoring Devices Market Size, by Country/ Region, 2015-2022 (USD Million)
  • Table 9: Global Continuous Glucose Monitoring Devices Market Size, by Country/ Region, 2015-2022 (USD Million)
  • Table 10: Global Test Strips Market Size, by Country/ Region, 2015-2022 (USD Million)
  • Table 11: Global Lancets Market Size, by Country/ Region, 2015-2022 (USD Million)
  • Table 12: Global Self-Monitoring Bloob Glucose Devices Market Size, by Country/ Region, 2015-2022 (USD Million)
  • Table 13: Global Hemoglobin A1c Testing Kits Market Size, by Country/ Region, 2015-2022 (USD Million)
  • Table 14: Global Insulin Delivery Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 15: Global Insulin Delivery Devices Market Size, by Country/ Region, 2015-2022 (USD Million)
  • Table 16: Global Insulin Syringes Market Size, by Country/ Region, 2015-2022 (USD Million)
  • Table 17: Global Insulin Pens Market Size, by Country/ Region, 2015-2022 (USD Million)
  • Table 18: Global Insulin Pumps Market Size, by Country/ Region, 2015-2022 (USD Million)
  • Table 19: Global Insulin Jet Injectors Market Size, by Country/ Region, 2015-2022 (USD Million)
  • Table 20: Global Diabetes Care Drugs Market Size, by Type, 2015-2022 (USD Million)
  • Table 21: Global Diabetes Care Drugs Market Size, by Country/ Region, 2015-2022 (USD Million)
  • Table 22: Global Insulin Market Size, by Type, 2015-2022 (USD Million)
  • Table 23: Global Insulin Market Size, by Country/ Region, 2015-2022 (USD Million)
  • Table 24: Global Rapid-Acting Insulin Market Size, by Country/ Region, 2015-2022 (USD Million)
  • Table 25: Global Short-Acting Insulin Market Size, by Country/ Region, 2015-2022 (USD Million)
  • Table 26: Global Intermediate-Acting Insulin Market Size, by Country/ Region, 2015-2022 (USD Million)
  • Table 27: Global Long-Acting Insulin Market Size, by Country/ Region, 2015-2022 (USD Million)
  • Table 28: Global Oral-Hypoglycaemic Drugs Market Size, by Type, 2015-2022 (USD Million)
  • Table 29: Global Oral-Hypoglycaemic Drugs Market Size, by Country/ Region, 2015-2022 (USD Million)
  • Table 30: Global Sulfonylureas Market Size, by Country/ Region, 2015-2022 (USD Million)
  • Table 31: Global Biguanides Market Size, by Country/ Region, 2015-2022 (USD Million)
  • Table 32: Global Meglitinides/ Phenylalanine Analogues Market Size, by Country/ Region, 2015-2022 (USD Million)
  • Table 33: Global Thiazolidinedione Analogues Market Size, by Country/ Region, 2015-2022 (USD Million)
  • Table 34: Global Alpha-Glucosidase Inhibitors Market Size, by Country/ Region, 2015-2022 (USD Million)
  • Table 35: Global DPP-4 Inhibitors Market Size, by Country/ Region, 2015-2022 (USD Million)
  • Table 36: Global Non-Insulin Injectable Drugs Market Size, by Country/ Region, 2015-2022 (USD Million)
  • Table 37: Global Diabetes Care Devices & Drugs Market Size, by Country/ Region, 2015-2022 (USD Million)
  • Table 38: North America: Diabetes Care Devices & Drugs Market Size, by Type, 2015-2022 (USD Million)
  • Table 39: North America: Diabetes Care Devices & Drugs Market Size, by Country, 2015-2022 (USD Million)
  • Table 40: North America: Diabetes Care Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 41: North America: Diabetes Monitoring Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 42: North America: Insulin Delivery Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 43: North America: Diabetes Care Drugs Market Size, by Type, 2015-2022 (USD Million)
  • Table 44: North America: Insulin Market Size, by Type, 2015-2022 (USD Million)
  • Table 45: North America: Oral-Hypoglycaemic Drugs Market Size, by Type, 2015-2022 (USD Million)
  • Table 46: U.S.: Diabetes Indicators, 2016
  • Table 47: Estimated Number and Percentage of Diagnosed And Undiagnosed Diabetes Among Adults Aged =18 Years, U.S., 2015
  • Table 48: Drugs Approved by FDA From 2012-2017 for Treatment of Diabetes
  • Table 49: U.S.: Diabetes Care Devices & Drugs Market, by Type, 2015-2022 (USD Million)
  • Table 50: U.S.: Diabetes Care Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 51: U.S.: Diabetes Monitoring Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 52: U.S.: Insulin Delivery Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 53: U.S.: Diabetes Care Drugs Market Size, by Type, 2015-2022 (USD Million)
  • Table 54: U.S.: Insulin Market Size, by Type, 2015-2022 (USD Million)
  • Table 55: U.S.: Oral-Hypoglycaemic Drugs Market Size, by Type, 2015-2022 (USD Million)
  • Table 56: Diabetes Statistics in Canada, 2016-2026
  • Table 57: Canada: Diabetes Indicators, 2016
  • Table 58: Canada: Diabetes Care Devices & Drugs Market, by Type, 2015-2022 (USD Million)
  • Table 59: Canada: Diabetes Care Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 60: Canada: Diabetes Monitoring Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 61: Canada: Insulin Delivery Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 62: Canada: Diabetes Care Drugs Market Size, by Type, 2015-2022 (USD Million)
  • Table 63: Canada: Insulin Market Size, by Type, 2015-2022 (USD Million)
  • Table 64: Canada: Oral-Hypoglycaemic Drugs Market Size, by Type, 2015-2022 (USD Million)
  • Table 65: Europe: Diabetes Care Devices & Drugs Market, by Type, 2015-2022 (USD Million)
  • Table 66: Europe: Diabetes Care Devices & Drugs Market Size, by Country, 2015-2022 (USD Million)
  • Table 67: Europe: Diabetes Care Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 68: Europe: Diabetes Monitoring Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 69: Europe: Insulin Delivery Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 70: Europe: Diabetes Care Drugs Market Size, by Type, 2015-2022 (USD Million)
  • Table 71: Europe: Insulin Market Size, by Type, 2015-2022 (USD Million)
  • Table 72: Europe: Oral-Hypoglycaemic Drugs Market Size, by Type, 2015-2022 (USD Million)
  • Table 73: Germany: Diabetes Indiactors, 2016
  • Table 74: Germany: Diabetes Care Devices & Drugs Market, by Type, 2015-2022 (USD Million)
  • Table 75: Germany: Diabetes Care Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 76: Germany: Diabetes Monitoring Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 77: Germany: Insulin Delivery Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 78: Germany: Diabetes Care Drugs Market Size, by Type, 2015-2022 (USD Million)
  • Table 79: Germany: Insulin Market Size, by Type, 2015-2022 (USD Million)
  • Table 80: Germany: Oral-Hypoglycaemic Drugs Market Size, by Type, 2015-2022 (USD Million)
  • Table 81: France: Diabetes Indicators, 2016
  • Table 82: France: Diabetes Care Devices & Drugs Market, by Type, 2015-2022 (USD Million)
  • Table 83: France: Diabetes Care Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 84: France: Diabetes Monitoring Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 85: France: Insulin Delivery Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 86: France: Diabetes Care Drugs Market Size, by Type, 2015-2022 (USD Million)
  • Table 87: France: Insulin Market Size, by Type, 2015-2022 (USD Million)
  • Table 88: France: Oral-Hypoglycaemic Drugs Market Size, by Type, 2015-2022 (USD Million)
  • Table 89: Italy: Diabetes Indicators, 2016
  • Table 90: Italy: Diabetes Care Devices & Drugs Market, by Type, 2015-2022 (USD Million)
  • Table 91: Italy: Diabetes Care Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 92: Italy: Diabetes Monitoring Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 93: Italy: Insulin Delivery Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 94: Italy: Diabetes Care Drugs Market Size, by Type, 2015-2022 (USD Million)
  • Table 95: Italy: Insulin Market Size, by Type, 2015-2022 (USD Million)
  • Table 96: Italy: Oral-Hypoglycaemic Drugs Market Size, by Type, 2015-2022 (USD Million)
  • Table 97: Spain: Diabetes Indicators, 2016
  • Table 98: Spain: Diabetes Care Devices & Drugs Market, by Type, 2015-2022 (USD Million)
  • Table 99: Spain: Diabetes Care Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 100: Spain: Diabetes Monitoring Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 101: Spain: Insulin Delivery Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 102: Spain: Diabetes Care Drugs Market Size, by Type, 2015-2022 (USD Million)
  • Table 103: Spain: Insulin Market Size, by Type, 2015-2022 (USD Million)
  • Table 104: Spain: Oral-Hypoglycaemic Drugs Market Size, by Type, 2015-2022 (USD Million)
  • Table 105: U.K.: Diabetes Indicators, 2016
  • Table 106: U.K.: Diabetes Care Devices & Drugs Market, by Type, 2015-2022 (USD Million)
  • Table 107: U.K: Diabetes Care Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 108: U.K: Diabetes Monitoring Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 109: U.K.: Insulin Delivery Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 110: U.K.: Diabetes Care Drugs Market Size, by Type, 2015-2022 (USD Million)
  • Table 111: U.K.: Insulin Market Size, by Type, 2015-2022 (USD Million)
  • Table 112: U.K.: Oral-Hypoglycaemic Drugs Market Size, by Type, 2015-2022 (USD Million)
  • Table 113: RoE: Diabetes Care Devices & Drugs Market, by Type, 2015-2022 (USD Million)
  • Table 114: RoE: Diabetes Care Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 115: RoE: Diabetes Monitoring Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 116: RoE: Insulin Delivery Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 117: RoE: Diabetes Care Drugs Market Size, by Type, 2015-2022 (USD Million)
  • Table 118: RoE: Insulin Market Size, by Type, 2015-2022 (USD Million)
  • Table 119: RoE: Oral-Hypoglycaemic Drugs Market Size, by Type, 2015-2022 (USD Million)
  • Table 120: APAC: Diabetes Care Devices & Drugs Market, by Type, 2015-2022 (USD Million)
  • Table 121: APAC: Diabetes Care Devices Market Size, by Country, 2015-2022 (USD Million)
  • Table 122: APAC: Diabetes Care Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 123: APAC: Diabetes Monitoring Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 124: APAC: Insulin Delivery Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 125: APAC: Diabetes Care Drugs Market Size, by Type, 2015-2022 (USD Million)
  • Table 126: APAC: Insulin Market Size, by Type, 2015-2022 (USD Million)
  • Table 127: APAC: Oral-Hypoglycaemic Drugs Market Size, by Type, 2015-2022 (USD Million)
  • Table 128: Japan: Diabetes Indicators, 2016
  • Table 129: Japan: Diabetes Care Devices & Drugs Market, by Type, 2015-2022 (USD Million)
  • Table 130: Japan: Diabetes Care Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 131: Japan: Diabetes Monitoring Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 132: Japan: Insulin Delivery Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 133: Japan: Diabetes Care Drugs Market Size, by Type, 2015-2022 (USD Million)
  • Table 134: Japan: Insulin Market Size, by Type, 2015-2022 (USD Million)
  • Table 135: Japan: Oral-Hypoglycaemic Drugs Market Size, by Type, 2015-2022 (USD Million)
  • Table 136: China: Diabetes Indicators, 2016
  • Table 137: China: Diabetes Care Devices & Drugs Market, by Type, 2015-2022 (USD Million)
  • Table 138: China: Diabetes Care Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 139: China: Diabetes Monitoring Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 140: China: Insulin Delivery Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 141: China: Diabetes Care Drugs Market Size, by Type, 2015-2022 (USD Million)
  • Table 142: China: Insulin Market Size, by Type, 2015-2022 (USD Million)
  • Table 143: China: Oral-Hypoglycaemic Drugs Market Size, by Type, 2015-2022 (USD Million)
  • Table 144: India: Diabetes Indicators, 2016
  • Table 145: India: Diabetes Care Devices & Drugs Market, by Type, 2015-2022 (USD Million)
  • Table 146: India: Diabetes Care Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 147: India: Diabetes Monitoring Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 148: India: Insulin Delivery Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 149: India: Diabetes Care Drugs Market Size, by Type, 2015-2022 (USD Million)
  • Table 150: India: Insulin Market Size, by Type, 2015-2022 (USD Million)
  • Table 151: India: Oral-Hypoglycaemic Drugs Market Size, by Type, 2015-2022 (USD Million)
  • Table 152: RoAPAC: Diabetes Care Devices & Drugs Market, by Type, 2015-2022 (USD Million)
  • Table 153: RoAPAC: Diabetes Care Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 154: RoAPAC: Diabetes Monitoring Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 155: RoAPAC: Insulin Delivery Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 156: RoAPAC: Diabetes Care Drugs Market Size, by Type, 2015-2022 (USD Million)
  • Table 157: RoAPAC: Insulin Market Size, by Type, 2015-2022 (USD Million)
  • Table 158: RoAPAC: Oral-Hypoglycaemic Drugs Market Size, by Type, 2015-2022 (USD Million)
  • Table 159: RoW: Diabetes Care Devices & Drugs Market, by Type, 2015-2022 (USD Million)
  • Table 160: RoW: Diabetes Care Devices Market Size, by Country, 2015-2022 (USD Million)
  • Table 161: RoW: Diabetes Care Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 162: RoW: Diabetes Monitoring Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 163: RoW: Insulin Delivery Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 164: RoW: Diabetes Care Drugs Market Size, by Type, 2015-2022 (USD Million)
  • Table 165: RoW: Insulin Market Size, by Type, 2015-2022 (USD Million)
  • Table 166: RoW: Oral-Hypoglycaemic Drugs Market Size, by Type, 2015-2022 (USD Million)
  • Table 167: Latin America: Diabetes Care Devices & Drugs Market, by Type, 2015-2022 (USD Million)
  • Table 168: Latin America: Diabetes Care Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 169: Latin America: Diabetes Monitoring Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 170: Latin America: Insulin Delivery Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 171: Latin America: Diabetes Care Drugs Market Size, by Type, 2015-2022 (USD Million)
  • Table 172: Latin America: Insulin Market Size, by Type, 2015-2022 (USD Million)
  • Table 173: Latin America: Oral Hypoglycaemic Drugs Market Size, by Type, 2015-2022 (USD Million)
  • Table 174: Middle East & Africa: Diabetes Care Devices & Drugs Market, by Type, 2015-2022 (USD Million)
  • Table 175: Middle East & Africa: Diabetes Care Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 176: Middle East & Africa: Diabetes Monitoring Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 177: Middle East & Africa: Insulin Delivery Devices Market Size, by Type, 2015-2022 (USD Million)
  • Table 178: Middle East & Africa: Diabetes Care Drugs Market Size, by Type, 2015-2022 (USD Million)
  • Table 179: Middle East & Africa: Insulin Market Size, by Type, 2015-2022 (USD Million)
  • Table 180: Middle East & Africa: Oral-Hypoglycaemic Drugs Market Size, by Type, 2015-2022 (USD Million)
  • Table 181: Number of Developments by the Key Companies, 2015-2017

List of Figures

  • Figure 1: Research Process
  • Figure 2: Key Executives Interviewed
  • Figure 3: Primary Research Techniques
  • Figure 4: Key Opportunities
  • Figure 5: Global Diabetes Care Devices & Drugs Market Size, by Type, 2015-2022 (USD Million)
  • Figure 6: Diabetes Monitoring Devices Dominates Diabetes Care Devices Market
  • Figure 7: Diabetes Care Devices & Drugs Market Overview- 2017-2022
  • Figure 8: Key Growth Strategies Adopted by the Leading Players -2015-2017
  • Figure 9: Market Dynamics
  • Figure 10: Rising Overweight (Including Obesity) Rates in Adults Aged 15-74 Years
  • Figure 11: Market Share Analysis: Diabetes Care Devices Market, 2016
  • Figure 12: Market Share Analysis: Diabetes Care Drugs Market, 2016
  • Figure 13: Global Diabetes Care Devices Market Size, by Type, 2015-2022
  • Figure 14: Global Diabetes Care Drugs Market Size, by Type, 2015-2022
  • Figure 15: Global Diabetes Care Devices & Drugs Market Size, by Country/ Region, 2015-2022 (USD Million)
  • Figure 16: Mortality Due to Diabetes in North America, By Age Group, 2015
  • Figure 17: A Snapshot of Diabetes in The U.S., 2017
  • Figure 18: Cost of Diabetes in Canada, 2000-2020
  • Figure 19: Comparative Prevalence of Diabetes in Adults in EU Countries, 2016
  • Figure 20: Percentage of Total Death, 2016
  • Figure 21: Number of Patients with Type-2 Diabetes in Germany, 2006-2014
  • Figure 22: Distribution of Total Expenditure Per Healthcare Item, 2013
  • Figure 23: Projected Rate of Obesity, 2000-2030
  • Figure 24: Facts & Figures of Diabetes in Italy, 2016
  • Figure 25: Diabetes Prevalence in EU Member Countries, 2017
  • Figure 26: Prevalence of Diabetes in Japan, 2000-2030
  • Figure 27: Healthcare Costs for Diabetes by Latin American Countries, 2010-2025 (USD Million)
  • Figure 28: Key Growth Strategies Adopted by Key Players -2015-2017
  • Figure 29: Partnerships, Agreements & Collaborations by Profiled Companies, 2015-2017
  • Figure 30: Approvals Received by Profiled Companies, 2015-2017
  • Figure 31: New Product Launches by Profiled Companies, 2015-2017
  • Figure 32: Expansions by Profiled Companies, 2015-2017
  • Figure 33: Novo Nordisk A/S: Financial Overview- 2014-2016
  • Figure 34: Ypsomed Ag: Financial Overview- 2015-2017
  • Figure 35: Abbott Labratories: Financial Overview- 2014-2016
  • Figure 36: Panasonic Corporation (A Parent Company of Ascensia Diabetes Care Holdings Ag): Financial Overview- 2015-2017
  • Figure 37: Eli Lilly And Company: Financial Overview- 2014-2016
  • Figure 38: Hoffmann-La Roche Ltd.: Financial Overview- 2014-2016
  • Figure 39: Johnson & Johnson: Financial Overview- 2014-2016
  • Figure 40: Medtronic Plc: Financial Overview- 2015-2017
  • Figure 41: Becton, Dickinson And Company: Financial Overview- 2014-2016
  • Figure 42: Terumo Corporation: Financial Overview- 2014-2016
  • Figure 43: Sanofi S.A.: Financial Overview- 2014-2016
  • Figure 44: Merck & Co., Inc.: Financial Overview- 2014-2016
  • Figure 45: Novartis AG: Financial Overview- 2014-2016
  • Figure 46: Astrazeneca: Financial Overview- 2014-2016
  • Figure 47: Boehringer Ingelheim GmbH: Financial Overview- 2014-2016
Back to Top